Penny stock Zomedica jumps 250% after someone paid Netflix star Carole Baskin $299 for a mention
Little known Michigan-based animal health and veterinarian penny stock Zomedica surged nearly 250% since earning a mention from Netflix’s “Tiger King” star Carole Baskin last week. In a video re-posted to YouTube, Baskin delivers a glowing review for the company, saying "I don't know if you guys have heard about Zomedica, but they help our veterinarians and our furry friends” and that she is “definitely invested in finding out more” about the company.
But Yahoo Finance has confirmed that what appeared to be an endorsement from Baskin was nothing more than the result of a request from someone on Cameo, a platform where users can pay for video messages.
“It was a Cameo they paid for,” Baskin told Yahoo Finance. “I don't hold any stock in the company and don't make stock recommendations.”
It’s also possible the request could have come from an outside investor looking to spark an increase in the share price that sat at just $0.40 last week.
The Ann Arbor, Michigan-based company, which went public in 2016, has yet to achieve any revenue, according to financial statements
The penny stock was also among the most actively traded by volume on popular retail investor platform Robinhood, according to analytics firm Breakout Point.
Baskin says she wasn’t able to recall who ordered the message that requested she seemingly endorse the upcoming launch of Zomedica’s testing platform for disorders in dogs and cats. In Baskin’s video, she echoes that “they think it’s going to be a really big seller.”
Baskin expressed her doubts that she alone could have influenced the excitement.
finance.yahoo.com/ne...ntion-225328904.html
Little known Michigan-based animal health and veterinarian penny stock Zomedica surged nearly 250% since earning a mention from Netflix’s “Tiger King” star Carole Baskin last week. In a video re-posted to YouTube, Baskin delivers a glowing review for the company, saying "I don't know if you guys have heard about Zomedica, but they help our veterinarians and our furry friends” and that she is “definitely invested in finding out more” about the company.
But Yahoo Finance has confirmed that what appeared to be an endorsement from Baskin was nothing more than the result of a request from someone on Cameo, a platform where users can pay for video messages.
“It was a Cameo they paid for,” Baskin told Yahoo Finance. “I don't hold any stock in the company and don't make stock recommendations.”
It’s also possible the request could have come from an outside investor looking to spark an increase in the share price that sat at just $0.40 last week.
The Ann Arbor, Michigan-based company, which went public in 2016, has yet to achieve any revenue, according to financial statements
The penny stock was also among the most actively traded by volume on popular retail investor platform Robinhood, according to analytics firm Breakout Point.
Baskin says she wasn’t able to recall who ordered the message that requested she seemingly endorse the upcoming launch of Zomedica’s testing platform for disorders in dogs and cats. In Baskin’s video, she echoes that “they think it’s going to be a really big seller.”
Baskin expressed her doubts that she alone could have influenced the excitement.
finance.yahoo.com/ne...ntion-225328904.html